210 related articles for article (PubMed ID: 22742818)
1. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
Makedonov I; Black SE; MacIntosh BJ
Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
[TBL] [Abstract][Full Text] [Related]
2. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.
Holland CM; Smith EE; Csapo I; Gurol ME; Brylka DA; Killiany RJ; Blacker D; Albert MS; Guttmann CR; Greenberg SM
Stroke; 2008 Apr; 39(4):1127-33. PubMed ID: 18292383
[TBL] [Abstract][Full Text] [Related]
3. Association between hypertension and neurovascular inflammation in both normal-appearing white matter and white matter hyperintensities.
Solé-Guardia G; Custers E; de Lange A; Clijncke E; Geenen B; Gutierrez J; Küsters B; Claassen JAHR; de Leeuw FE; Wiesmann M; Kiliaan AJ
Acta Neuropathol Commun; 2023 Jan; 11(1):2. PubMed ID: 36600303
[TBL] [Abstract][Full Text] [Related]
4. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
[TBL] [Abstract][Full Text] [Related]
5. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
[TBL] [Abstract][Full Text] [Related]
8. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?
Brickman AM; Muraskin J; Zimmerman ME
Dialogues Clin Neurosci; 2009; 11(2):181-90. PubMed ID: 19585953
[TBL] [Abstract][Full Text] [Related]
9. BOLD fMRI in the white matter as a marker of aging and small vessel disease.
Makedonov I; Black SE; Macintosh BJ
PLoS One; 2013; 8(7):e67652. PubMed ID: 23844047
[TBL] [Abstract][Full Text] [Related]
10. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.
Birdsill AC; Koscik RL; Jonaitis EM; Johnson SC; Okonkwo OC; Hermann BP; Larue A; Sager MA; Bendlin BB
Neurobiol Aging; 2014 Apr; 35(4):769-76. PubMed ID: 24199958
[TBL] [Abstract][Full Text] [Related]
11. White matter hyperintensities segmentation using the ensemble U-Net with multi-scale highlighting foregrounds.
Park G; Hong J; Duffy BA; Lee JM; Kim H
Neuroimage; 2021 Aug; 237():118140. PubMed ID: 33957235
[TBL] [Abstract][Full Text] [Related]
12. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
[TBL] [Abstract][Full Text] [Related]
13. [White Matter Lesion and Alzheimer's Disease: The Association between Small Vessel Disease and Neuropsychiatric Symptoms in Alzheimer's Disease].
Hashimoto M; Ikeda M
Brain Nerve; 2015 Apr; 67(4):427-32. PubMed ID: 25846591
[TBL] [Abstract][Full Text] [Related]
14. Free-water diffusion MRI detects structural alterations surrounding white matter hyperintensities in the early stage of cerebral small vessel disease.
Mayer C; Nägele FL; Petersen M; Frey BM; Hanning U; Pasternak O; Petersen E; Gerloff C; Thomalla G; Cheng B
J Cereb Blood Flow Metab; 2022 Sep; 42(9):1707-1718. PubMed ID: 35410517
[TBL] [Abstract][Full Text] [Related]
15. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.
Shirzadi Z; Schultz SA; Yau WW; Joseph-Mathurin N; Fitzpatrick CD; Levin R; Kantarci K; Preboske GM; Jack CR; Farlow MR; Hassenstab J; Jucker M; Morris JC; Xiong C; Karch CM; Levey AI; Gordon BA; Schofield PR; Salloway SP; Perrin RJ; McDade E; Levin J; Cruchaga C; Allegri RF; Fox NC; Goate A; Day GS; Koeppe R; Chui HC; Berman S; Mori H; Sanchez-Valle R; Lee JH; Rosa-Neto P; Ruthirakuhan M; Wu CY; Swardfager W; Benzinger TLS; Sohrabi HR; Martins RN; Bateman RJ; Johnson KA; Sperling RA; Greenberg SM; Schultz AP; Chhatwal JP;
JAMA Neurol; 2023 Dec; 80(12):1353-1363. PubMed ID: 37843849
[TBL] [Abstract][Full Text] [Related]
16. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
[TBL] [Abstract][Full Text] [Related]
17. Oxygen Metabolic Stress and White Matter Injury in Patients With Cerebral Small Vessel Disease.
Kang P; Ying C; Chen Y; Ford AL; An H; Lee JM
Stroke; 2022 May; 53(5):1570-1579. PubMed ID: 34886686
[TBL] [Abstract][Full Text] [Related]
18. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
19. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
[TBL] [Abstract][Full Text] [Related]
20. Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia.
Huang CC; Liu ME; Chou KH; Yang AC; Hung CC; Hong CJ; Tsai SJ; Lin CP
Psychoneuroendocrinology; 2014 Jan; 39():94-103. PubMed ID: 24275008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
